ESCC
Clinical trials for ESCC explained in plain language.
Never miss a new study
Get alerted when new ESCC trials appear
Sign up with your email to follow new studies for ESCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy trial aims to fight esophageal cancer in seniors
Disease control Not yet recruitingThis study is testing whether combining a drug called TAS-102 with radiation therapy is safe and effective for elderly patients with locally advanced esophageal cancer. The goal is to control the cancer and improve survival rates. The research will first find the safest dose of t…
Matched conditions: ESCC
Phase: PHASE1, PHASE2 • Sponsor: Qianfoshan Hospital • Aim: Disease control
Last updated Apr 03, 2026 21:25 UTC
-
Two-Pronged attack: new drug combo aims to shrink tumors before esophageal cancer surgery
Disease control Not yet recruitingThis study is testing whether a new two-drug immunotherapy (iparomlimab and tuvonralimab) combined with a chemotherapy drug (nab-paclitaxel) can help shrink tumors before surgery for people with a type of esophageal cancer. The goal is to see if this 'neoadjuvant' treatment makes…
Matched conditions: ESCC
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
New drug cocktail aims to wipe out tumors before esophageal cancer surgery
Disease control Not yet recruitingThis study is testing a new combination of immunotherapy and chemotherapy drugs given to patients before surgery for esophageal cancer. The goal is to see if this pre-surgery treatment can completely eliminate the cancer in the removed tumor and improve long-term survival. The st…
Matched conditions: ESCC
Phase: NA • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC